Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?

NCT02526680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-12-13

Study results available
· View outcomes & findings →

Summary

To determine the impact of OrCam over 1 month on health-related quality of life (HRQoL) in subjects with advanced glaucoma using the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25).

To identify tasks for which subjects are using the OrCam device and patient satisfaction.

Conditions

Interventions

DEVICE

OrCam

The OrCam low vision aid, camera attached to glasses, used by 27 glaucoma subjects for 1 month.

Sponsors & Collaborators

  • Wills Eye

    lead OTHER

Principal Investigators

  • L. Jay Katz, MD · Wills Eye Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-07-31
Completion
2015-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526680 on ClinicalTrials.gov